Share
255 Posts.
lightbulb Created with Sketch. 50
clock Created with Sketch. 24/05/25
11:29
Share
Originally posted by RaceOncology:
↑
The unknown is not if RC220 is going to behave the same as RC110 (it will), not least because the variation between patients is greater than any possible slight difference in PK/PD between the two forms. The unknown is if RC220 will be cardioprotective when used in combination with doxorubicin. This has never been done before in patients. Everyone needs to estimate how likely this will be true - I think likely, but I have an unfair advantage in knowing the mechanism of action.
Expand
There is one final kicker - what if Race is able to find some major use for RC220 that is unexpected from the historical trials.
(20min delay)